Sorafenib

Sorafenib
Trade Name Nexavar
Orphan Indication Renal cancer
USA Market Approval USA
USA Designation Date 2004-10-08 00:00:00
Sponsor Bayer Pharmaceutical Corporation;400 Morgan Lane;West Haven, Connecticut, 06516